Abingdon Analytical

UKAS-accredited stability, shelf-life and method validation testing for diagnostic and medical device developers

York, United KingdomFounded 2024abingdonhealth.comWebsite technologies

+ Add to sales board

Highlights

  • Young companyFounded 2024
  • New on EvolcAdded 2026-10-28

About Abingdon Analytical

Abingdon Analytical is the analytical division of Abingdon Health, an AIM-listed diagnostics contract development and manufacturing group. It runs accredited laboratory services covering stability studies, shelf-life determination, method validation, bioburden and biocompatibility testing, and clinical trial and CRO services.

The parent group describes its customers as pharmaceutical companies, biotech firms, government bodies and NGOs. The division's services are sold as testing and laboratory work for clients developing diagnostic tests and medical devices.

Abingdon Analytical Limited is registered in England, with its headquarters in York. Its UKAS-accredited analytical laboratory is in Doncaster. The division sits within the Abingdon Health group, which was founded in 2008 and has been listed on AIM since 2020.

Product: Stability studies, shelf-life determination, method validation, bioburden and biocompatibility testing, and clinical trial and CRO services.

Jobs at Abingdon Analytical

No open positions listed right now.

Leadership

More biotech & pharma companies

  • Actimed Therapeutics

    Clinical-stage drug developer targeting cancer cachexia and muscle wasting with S-pindolol benzoate in Phase 2
    Ascot, United KingdomBiotech & pharmaFounded 2016
    New on Evolc
  • Adaptimmune

    Develops engineered T-cell therapies for people with cancer
    Abingdon, United KingdomBiotech & pharmaFounded 2007
    New on Evolc
  • Ads Biotec

    Automated laboratory instruments, consumables and purification solutions for cytogenetic, pathology and research labs
    Cambridge, United KingdomBiotech & pharmaFounded 1996
    New on Evolc
  • Aixcell

    Autonomous cell culture system running routine and multi-project cell-based workflows for AI/ML data generation
    Cambridge, United KingdomBiotech & pharmaFounded 2019
    New on Evolc
  • Alimera Sciences

    Develops and commercialises ophthalmic medicines for patients with chronic retinal diseases
    Hook, United KingdomBiotech & pharmaFounded 2012
    New on Evolc
  • Amphista Therapeutics

    Develops Targeted Glue protein-degrader medicines for cancer, with a lead acute myeloid leukemia candidate in Phase 1
    Cambridge, United KingdomBiotech & pharmaFounded 2017
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Cloudflare
  • Complianz
  • Google Analytics 4
  • HubSpot
  • WordPress